Induction of Donor-Specific Tolerance in Recipients of Live Donor Stem Cell Infusion (Compassionate Use)
NCT02051673 · Status: NO_LONGER_AVAILABLE · Type: EXPANDED_ACCESS
Last updated 2022-07-18
Summary
Four subjects were treated under compassionate use provisions under this study with facilitating cell therapy (FCRx)
Conditions
- Renal Failure
Interventions
- BIOLOGICAL
-
Biological/Vaccine: Enriched Hematopoetic Stem Cell Infusion
Enriched Hematopoetic Stem Cell Infusion
Sponsors & Collaborators
- collaborator OTHER
-
Talaris Therapeutics Inc.
lead INDUSTRY
Principal Investigators
-
Suzanne T Ildstad, MD · Talaris Therapeutics Inc.
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
Countries
- United States
Study Locations
More Related Trials
-
Improving Blood Stem Cell Collection and Transplant Procedures
NCT01517035 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Cell Therapy in Failure Syndromes in Limbal Stem Cells
NCT01619189 ·Status: COMPLETED ·Phase: PHASE2
-
Phase 1 Infused Donor T Regulatory Cells in Steroid Dependent/Refractory Chronic GVHD
NCT01911039 ·Status: COMPLETED ·Phase: PHASE1
-
Prevention of GVHD in Patients Treated With Allogeneic SCT: Possible Role of Extracorporeal Photophoresis
NCT03204721 ·Status: COMPLETED ·Phase: NA
-
Multicenter Clinical Trial for the Evaluation of Mesenchymal Stem Cells From Adipose Tissue in Patients With Chronic Graft Versus Host Disease.
NCT01222039 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Bone Marrow Stromal Cell Infusions for Stem Cell Transplant Complications
NCT01633229 ·Status: COMPLETED ·Phase: PHASE1
-
Extracorporeal Photopheresis and Mesenchymal Stem Cell Infusion for GVHD
NCT05333029 ·Status: WITHDRAWN ·Phase: PHASE2
-
Mesenchymal Stem Cell Infusion as Prevention for Graft Rejection and Graft-versus-host Disease
NCT00504803 ·Status: COMPLETED ·Phase: PHASE2
-
Stem Cell Transplantation and T-Cell Add-Back to Treat Bone Marrow Malignancies
NCT00079391 ·Status: COMPLETED ·Phase: PHASE2
-
FMT In High-Risk Acute GVHD After ALLO HCT
NCT04139577 ·Status: COMPLETED ·Phase: PHASE1
-
Long-Term Follow-up of People Undergoing Hematopoietic Stem Cell Transplantation
NCT03000244 ·Status: RECRUITING
-
Screening for Subjects to Participate in Studies of Blood Disorders
NCT00695123 ·Status: COMPLETED
-
Immunotherapy in Treating Patients Who Are Undergoing Bone Marrow or Peripheral Stem Cell Transplantation
NCT00002673 ·Status: COMPLETED ·Phase: PHASE2
-
Mesenchymal Stromal Cells in Kidney Transplant Recipients
NCT02012153 ·Status: TERMINATED ·Phase: PHASE1
-
A Multimodal Intervention to Address Sexual Dysfunction in Hematopoietic Stem Cell Transplant Survivors
NCT02492100 ·Status: COMPLETED ·Phase: NA
-
In-Vitro Studies in Depletion of Haplotype Mismatched Alloreactive T Cells
NCT00731705 ·Status: WITHDRAWN
-
Evaluation of Toxicity From Stem Cell Transplant
NCT00631787 ·Status: COMPLETED
-
Phase I Clinical Study of Haplo-HSCT Combined With Hypoxic 3D-Cultured Umbilical Cord MSC for the Treatment of SAA
NCT07299123 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE1/PHASE2
-
Long-Term Follow-Up Study of Human Stem Cells Transplanted in Subjects With Connatal Pelizaeus-Merzbacher Disease (PMD)
NCT01391637 ·Status: COMPLETED
-
Immunologic Diagnostic Blood Test in Predicting Side-Effects in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer or Other Diseases
NCT00813501 ·Status: TERMINATED
-
Long-Term Follow-Up of Transplanted Human Central Nervous System Stem Cells (HuCNS-SC) in Spinal Cord Trauma Subjects
NCT01725880 ·Status: TERMINATED
-
Haploidentical Hematopoietic Stem Cell Transplantation (HSCT) for Patients With Severe Sickle Cell Disease
NCT04207320 ·Status: TERMINATED ·Phase: NA
-
Conditioning Regimen Before Infusion of Allogeneic Hematopoietic Stem Cells
NCT00770523 ·Status: COMPLETED
-
Evaluation of Immunoregulatory Cells in Hematopoietic Stem Cell Transplant
NCT00179049 ·Status: COMPLETED
-
Evaluation of the Role of Mesenchymal Stem Cells in the Treatment of Graft Versus Host Disease
NCT00314483 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2